These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 17709640

  • 1. Distinct downregulation of C-type natriuretic peptide system in human aortic valve stenosis.
    Peltonen TO, Taskinen P, Soini Y, Rysä J, Ronkainen J, Ohtonen P, Satta J, Juvonen T, Ruskoaho H, Leskinen H.
    Circulation; 2007 Sep 11; 116(11):1283-9. PubMed ID: 17709640
    [Abstract] [Full Text] [Related]

  • 2. Statin treatment and gene expression of anti-atherogenic factor C-type natriuretic peptide system in stenotic aortic valves.
    Peltonen T, Ohtonen P, Näpänkangas J, Ohukainen P, Ruskoaho H, Taskinen P.
    J Heart Valve Dis; 2011 Sep 11; 20(5):545-51. PubMed ID: 22066359
    [Abstract] [Full Text] [Related]

  • 3. Natriuretic peptide system in the human retina.
    Rollín R, Mediero A, Roldán-Pallarés M, Fernández-Cruz A, Fernández-Durango R.
    Mol Vis; 2004 Jan 09; 10():15-22. PubMed ID: 14737067
    [Abstract] [Full Text] [Related]

  • 4. Increased expression of profibrotic neutral endopeptidase and bradykinin type 1 receptors in stenotic aortic valves.
    Helske S, Laine M, Kupari M, Lommi J, Turto H, Nurmi L, Tikkanen I, Werkkala K, Lindstedt KA, Kovanen PT.
    Eur Heart J; 2007 Aug 09; 28(15):1894-903. PubMed ID: 17507367
    [Abstract] [Full Text] [Related]

  • 5. Expression of natriuretic peptide system during embryonic stem cell vasculogenesis.
    Doi K, Itoh H, Nakagawa O, Igaki T, Yamashita J, Chun TH, Inoue M, Masatsugu K, Nakao K.
    Heart Vessels; 1997 Aug 09; Suppl 12():18-22. PubMed ID: 9476535
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of myocardial estrogen receptors in human aortic stenosis.
    Nordmeyer J, Eder S, Mahmoodzadeh S, Martus P, Fielitz J, Bass J, Bethke N, Zurbrügg HR, Pregla R, Hetzer R, Regitz-Zagrosek V.
    Circulation; 2004 Nov 16; 110(20):3270-5. PubMed ID: 15533858
    [Abstract] [Full Text] [Related]

  • 7. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system.
    Chen HH, Burnett JC.
    J Cardiovasc Pharmacol; 1998 Nov 16; 32 Suppl 3():S22-8. PubMed ID: 9883743
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. C-type natriuretic peptide/guanylate cyclase B system in ATDC5 cells, a chondrogenic cell line.
    Suda M, Tanaka K, Yasoda A, Komatsu Y, Chusho H, Miura M, Tamura N, Ogawa Y, Nakao K.
    J Bone Miner Metab; 2002 Nov 16; 20(3):136-41. PubMed ID: 11984695
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular characterisation and functional interrogation of a local natriuretic peptide system in rodent pituitaries, alphaT3-1 and LbetaT2 gonadotroph cells.
    Thompson IR, Chand AN, Jonas KC, Burrin JM, Steinhelper ME, Wheeler-Jones CP, McArdle CA, Fowkes RC.
    J Endocrinol; 2009 Nov 16; 203(2):215-29. PubMed ID: 19666697
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor-secreting mast cells and myofibroblasts: a novel self-perpetuating angiogenic pathway in aortic valve stenosis.
    Syväranta S, Helske S, Laine M, Lappalainen J, Kupari M, Mäyränpää MI, Lindstedt KA, Kovanen PT.
    Arterioscler Thromb Vasc Biol; 2010 Jun 16; 30(6):1220-7. PubMed ID: 20299690
    [Abstract] [Full Text] [Related]

  • 15. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
    Yeghiazaryan K, Skowasch D, Bauriedel G, Schild H, Golubnitschaja O.
    Amino Acids; 2007 Jan 16; 32(1):109-14. PubMed ID: 16874466
    [Abstract] [Full Text] [Related]

  • 16. Systemic and local levels of fetuin-A in calcific aortic valve stenosis.
    Kaden JJ, Reinöhl JO, Blesch B, Brueckmann M, Haghi D, Borggrefe M, Schmitz F, Klomfass S, Pillich M, Ortlepp JR.
    Int J Mol Med; 2007 Aug 16; 20(2):193-7. PubMed ID: 17611637
    [Abstract] [Full Text] [Related]

  • 17. Refining molecular pathways leading to calcific aortic valve stenosis by studying gene expression profile of normal and calcified stenotic human aortic valves.
    Bossé Y, Miqdad A, Fournier D, Pépin A, Pibarot P, Mathieu P.
    Circ Cardiovasc Genet; 2009 Oct 16; 2(5):489-98. PubMed ID: 20031625
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Atherosclerotic inflammation triggers osteogenic bone transformation in calcified and stenotic human aortic valves: still a matter of debate.
    Anger T, Carson W, Weyand M, Daniel WG, Hoeher M, Garlichs CD.
    Exp Mol Pathol; 2009 Feb 16; 86(1):10-7. PubMed ID: 19084515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.